
We were at Abradilan Conexão Farma 2026, at Expo Center Norte, in São Paulo, from 10 to 12 March. Andrea Gomes, Ederson Firmino, Marcelo Fantoni and Marcos Monzon dos Santos represented NimbusTax and ContaFarma across all three days.
The event is run by Abradilan, the pharmaceutical distribution association, and reached its 20th edition bringing together industry, distribution and retail. The Consumption Tax Reform was on the list of topics announced by the association and, in the Gestão 360º arena, the angle was its impact on working capital. That is the angle that matters to anyone running a pharmacy, and it is the one we deal with here.
What changes at the counter
Today most medicines reach the pharmacy with the tax already settled before it: PIS and Cofins (federal contributions levied on revenue) under the manufacturer's single-stage regime, and ICMS (Brazil's state tax on goods and services) charged in advance through tax substitution. The pharmacy resells with no new tax due.
Under IBS (Tax on Goods and Services) and CBS (Contribution on Goods and Services), that ends. Both are non-cumulative: you debit on the sale and take a credit on the purchase. The single-stage regime survives in the new system only for fuels (art. 172 of Complementary Law 214/2025). And tax substitution ends together with ICMS, in 2033, because it belongs to that tax.
In its place comes an item-by-item rule:
- Medicines in Annex XIV carry a zero IBS and CBS rate (art. 146). The list is exhaustive, by active ingredient and NCM (Mercosur product classification code).
- Other medicines registered with Anvisa (Brazil's health surveillance agency), or produced by a compounding pharmacy, carry a 60% reduction (art. 133) — an effective rate of 40% of the standard one.
- That reduction is conditional. §2º ties it to whoever manufactured or imported the item: either a conduct adjustment agreement with the federal government and the IBS Management Committee, or the CMED (Brazil's drug price regulation chamber) framework. The condition sits at the product's origin, not at the pharmacy that sells it.
- Beyond medicines, the rule continues. The personal hygiene and cleaning products in Annex VIII — soap, toothpaste, toothbrush, toilet paper, nappies, bleach — also carry a 60% reduction (art. 136). And sanitary pads, menstrual cups and period underwear carry a zero rate (art. 147), subject to Anvisa requirements. Perfumery and cosmetics do stay at the full rate.
- Sugar-sweetened drinks and tobacco products, when they are part of the range, also fall within the scope of the Selective Tax (art. 409, §1º). Medicines do not.
Add to that Annex VI — enteral and parenteral nutrition, formulas for inborn errors of metabolism —, reviewed every 120 days by force of art. 134: the list changes, and the product register has to keep up. In an operation with thin margins and a huge range, NCM, tax regime and classification stop being paperwork: they set the margin line by line.
The tax money no longer passes through the cash register
Complementary Law 214/2025 provides for split payment: the payment service provider separates out IBS and CBS in the financial settlement of the transaction itself (art. 31), before the money reaches the supplier (art. 32). For sales to final consumers there is a simplified alternative, with a predefined percentage (art. 33) — the over-the-counter case. In instalment sales, the split is proportional to each instalment (art. 34).
Anyone who today counts on the gap between being paid by the customer and paying the tax over needs to redo their cash flow: that gap shrinks.
The calendar is already running
According to the Receita Federal (Brazil's federal tax authority), 2026 is a test year: CBS at 0.9% and IBS at 0.1%, offsettable against PIS and Cofins liabilities, and already with tax documents required to state the new taxes. In 2027, PIS and Cofins are abolished and CBS starts to be charged. From 2029 to 2032, IBS gradually replaces ICMS and ISS (municipal tax on services), until it takes full effect in 2033.
There is also a short-deadline decision for anyone in the Simples Nacional (Brazil's simplified tax regime for small businesses). Art. 41, §3º allows IBS and CBS to be assessed under the regular regime without leaving Simples for the other taxes. A business that stays entirely in Simples passes on to the buyer a credit worth only the amount due under that regime — which weighs on the pharmacy that sells to clinics, companies and health plans. The election is made every six months, and the window that applies to the first half of 2027 runs from 1 to 30 September 2026, under CGSN Resolution No. 186/2026. Anyone who opts in and changes their mind can cancel up to the last day of November.
We came back from São Paulo with a practical conclusion: for the pharmacy, the reform is not a 2033 matter. It is product data, cash flow and a choice of regime with a deadline on 30 September.
This content is for information purposes only and does not replace a technical analysis of your company's specific situation.


